Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decreased Immunologic Activity”

862 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 862 results

Post-approval studies (Phase 4)UnknownNCT01095172
What this trial is testing

RituxiMab INDuction in Renal Transplantation

Who this might be right for
Function of Renal Transplant
Guy's and St Thomas' NHS Foundation Trust 100
Not applicableStudy completedNCT01356277
What this trial is testing

Intervention to Improve Adherence in Teen Kidney Transplant

Who this might be right for
Kidney TransplantationMedication Adherence
McGill University Health Centre/Research Institute of the McGill University Health Centre 170
Not applicableStudy completedNCT02902939
What this trial is testing

Myeloid-Derived Supressor Cells in Cardiac Surgery Patients

Who this might be right for
Insufficiency; Cardiac, Complicating SurgerySystemic Inflammatory Response Syndrome
Research Institute for Complex Problems of Cardiovascular Diseases, Russia 100
Not applicableEnded earlyNCT00663507
What this trial is testing

Kidney Transplantation in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 2
Not applicableStudy completedNCT05570643
What this trial is testing

The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Sepsis, Endotoxemia, Immunosuppression
Radboud University Medical Center 12
Not applicableStudy completedNCT01137084
What this trial is testing

Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

Who this might be right for
ImmunosuppressionHepatocellular CarcinomaLiver Transplantation+1 more
Shanghai Jiao Tong University School of Medicine 300
Testing effectiveness (Phase 2)UnknownNCT01198314
What this trial is testing

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

Who this might be right for
Liver Transplantation
The Catholic University of Korea 20
Post-approval studies (Phase 4)WithdrawnNCT03315052
What this trial is testing

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Who this might be right for
Acute Cellular Graft RejectionLiver Transplant Rejection
Montefiore Medical Center
Early research (Phase 1)Study completedNCT00007163
What this trial is testing

Monoclonal Antibody Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00217594
What this trial is testing

A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
National Heart, Lung, and Blood Institute (NHLBI) 40
Testing effectiveness (Phase 2)Study completedNCT00801632
What this trial is testing

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Who this might be right for
Kidney TransplantationKidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableStudy completedNCT02241564
What this trial is testing

Malignancies in Transplanted Patients

Who this might be right for
Neoplasms
Uppsala University 95
Not applicableNot Yet RecruitingNCT05482100
What this trial is testing

CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Transplant Genomics, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT04431219
What this trial is testing

First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

Who this might be right for
Kidney Transplant
Xenothera SAS 10
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Not applicableNot Yet RecruitingNCT07231328
What this trial is testing

PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)

Who this might be right for
Immunosuppression ManagementBiomarkers / BloodSubclinical Rejection+2 more
Transplant Genomics, Inc. 600
Large-scale testing (Phase 3)Ended earlyNCT04063865
What this trial is testing

Everolimus Monotherapy as Immunosuppression After Liver Transplant

Who this might be right for
Kidney Failure
Indiana University 14
Testing effectiveness (Phase 2)Study completedNCT00300521
What this trial is testing

Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Beijing Chao Yang Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00005935
What this trial is testing

Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 130
Load More Results